Rabbit Anti-Human Apolipoprotein AI Affinity Pure | ABMC-A03R

(No reviews yet) Write a Review

SKU:: ABMC-A03R
UPC:
MPN:
Availability:: Usually shipped in 5 working days

Select Currency //345.00 - Select Currency //553.00

Select your currency from the header

Current Stock:

Quantity:

Description
0 Reviews

Description

Rabbit Anti-Human Apolipoprotein AI Affinity Pure | ABMC-A03R

Host Species:	Rabbit
Concentration:	0.88 mg/ml (OD 1.35 / 280 nm)
Antigen:	Human Apolipoprotein AI
Purification:	Affinity purified
Buffer:	75 mM Sodium Phosphate, 75 mM NaCl, 0.5 mM EDTA, 0.02% NaN3, pH 7.2, with 30% glycerol
Specificity	Specifically binds to human apo AI. Dilution for immunoblot and ELISA range: 1,000 to 80,000.
Use:	The antibody can be used for detection of apo AI in plasma and lipoproteins, immunoassays, immunoblots, enzyme conjugation, or biotinylation.
Storage:	-20°C for long-term storage, 4°C for short- term storage. Aliquot to avoid repeated freezing and thawing.

*These products are for research or manufacturing use only, not for use in human therapeutic or diagnostic applications.

IMPORTANCE

Apo AI comprises approximately 70% of the protein moiety in HDL. It is a single polypeptide chain consisting of 243 amino acid residues without disulfide bound and with glutamic acid as the C-terminal residue and aspartic acid as the N-terminal residue. The molecular weight is reported to be 28 kDa (Brewer et al., 1978).

The roles of Apo AI in HDL function include reverse cholesterol transportation, lipid cholesterol binding, lecithin-cholesterol acyl transferase (LCAT) activation, and receptor binding, which is responsible for cholesterol esterification in plasma. Besides participate in cholesterol metabolism, Apo AI and HDL also suppress neutrophil activation, inhibit bacterial endotoxin, induce trypanosomal lysis, and other physiological activities. (Brouillette et al., 2001)

Apo AI levels may be inversely related to the risk of coronary disease. In previous research, Apo AI may affect diet-induced inflammation by either directly or indirectly altering lipid rafts. (Cheng et al., 2012)

View AllClose